Cite
HARVARD Citation
Yu, L. et al. (2021). MiR‐485‐3p serves as a biomarker and therapeutic target of Alzheimer's disease via regulating neuronal cell viability and neuroinflammation by targeting AKT3. Molecular genetics & genomic medicine. 9 (1), p. n/a. [Online].